Search Results - "Jensen, J.K."

Compositional variation effects on the microstructure and properties of a refractory high-entropy superalloy AlMo0.5NbTa0.5TiZr by Senkov, O.N., Jensen, J.K., Pilchak, A.L., Miracle, D.B., Fraser, H.L.

“…An AlMo0.5NbTa0.5TiZr baseline alloy was shown earlier to have good high temperature strength but poor ductility below 600°C due to coarse intermetallic grain…”
Get full text

Characterization of the microstructure of the compositionally complex alloy Al1Mo0.5Nb1Ta0.5Ti1Zr1 by Jensen, J.K., Welk, B.A., Williams, R.E.A., Sosa, J.M., Huber, D.E., Senkov, O.N., Viswanathan, G.B., Fraser, H.L.

“…Electron microscopy, X-ray energy dispersive spectroscopy, and tomographic reconstructions were used to characterize a high entropy alloy predominantly…”
Get full text

Soluble CXCL16 and long-term outcome in acute ischemic stroke by Ueland, T, Smedbakken, L.M, Hallén, J, Atar, D, Januzzi, J.L, Halvorsen, B, Jensen, J.K, Aukrust, P

“…Abstract Objective CXCL16 is a chemokine involved in atherosclerosis by promoting inflammation, lipid accumulation and matrix degradation. The level of…”
Get full text

Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke by Jensen, J K, Mickley, H, Bak, S, Korsholm, L, Kristensen, S R

“…The exact time-course of N-terminal pro-brain natriuretic peptide (NT-proBNP) and the prognostic importance in the immediate phase of ischemic stroke have not…”
Get more information

Daytime habitat selection for juvenile parr brown trout (Salmo trutta) in small lowland streams by Conallin, J., Boegh, E., Olsen, M., Pedersen, S., Dunbar, M.J., Jensen, J.K.

“…Physical habitat is important in determining the carrying capacity of juvenile brown trout, and within freshwater management. Summer daytime physical habitat…”
Get full text

A content review of state tobacco pre-emption laws in the US by Azagba, S., Ebling, T., Jensen, J.K., Hall, M.

“…State ceiling pre-emption laws effectively limit the authority of local governments to regulate numerous public health issues, including tobacco. While general…”
Get full text

Pressure-actuated microfluidic devices for electrophoretic separation of pre-term birth biomarkers by Sahore, V, Kumar, S, Rogers, C. I, Jensen, J. K, Sonker, M, Woolley, A. T

“…We have developed microfluidic devices with pressure-driven injection for electrophoretic analysis of amino acids, peptides, and proteins. The novelty of our…”
Get full text

Highly sensitive troponin T in patients with acute ischemic stroke by Jensen, J K, Ueland, T, Aukrust, P, Antonsen, L, Kristensen, S R, Januzzi, J L, Ravkilde, J

“…Newly developed troponin assays have superior diagnostic and prognostic performance in acute coronary syndrome (ACS), when compared to conventional troponin…”
Get more information

38 DEGARELIX VS. LEUPROLIDE TREATMENT IN PATIENTS WITH ADVANCED PROSTATE CANCER: PSA FAILURES DURING A RANDOMISED, PHASE III TRIAL (CS21) by Tombal, B, Miller, K, Boccon-Gibod, L, Schroder, F, Jensen, J.K, Olesen, T.K, Persson, B.-E

Get full text

39 COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT by Damber, J.E, Tammela, T, Abrahamsson, P.A, Iversen, P, Jensen, J.K, Olesen, T.K, Persson, B.-E

Get full text

40 DEGARELIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: EFFECT IN METASTATIC PATIENTS AS ASSESSED BY SERUM ALKALINE PHOSPHATASE by Schröder, F.H, Boccon-Gibod, L, Tombal, B, Miller, K, Jensen, J.K, Olesen, T.K, Persson, B.-E

Get full text

DEGARELIX COMPARED TO LEUPROLIDE DEPOT 7.5 MG IN A 12- MONTH RANDOMISED, OPEN-LABEL, PARALLEL-GROUP PHASE III STUDY IN PROSTATE CANCER PATIENTS by Boccon-Gibod, L, Klotz, L, Schröder, H, Andreou, C, Persson, B.E, Cantor, P, Jensen, J.K, Kold Olesen, T

Get full text

MP-08.18 by Iversen, P., Van Poppel, H., Tammela, T., de la Rosette, J., Johansson, J.E., Persson, B.E., Jensen, J.K., Olesen, T.K.

Get full text

MP-08.18: Determining the optimal initiation and maintenance dose of degarelix for hormone therapy of prostate cancer patients by Iversen, P., Van Poppel, H., Tammela, T., de la Rosette, J., Johansson, J.E., Persson, B.E., Jensen, J.K., Olesen, T.K.

Get full text

Silicates Eroded under Simulated Martian Conditions Effectively Kill Bacteria-A Challenge for Life on Mars by Bak, Ebbe N, Larsen, Michael G, Moeller, Ralf, Nissen, Silas B, Jensen, Lasse R, Nørnberg, Per, Jensen, Svend J K, Finster, Kai

“…The habitability of Mars is determined by the physical and chemical environment. The effect of low water availability, temperature, low atmospheric pressure…”
Get full text

Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis by Van de Kerkhof, P C M, Green, C, Hamberg, K J, Hutchinson, P E, Jensen, J K, Kidson, P, Kragballe, K, Larsen, F G, Munro, C S, Tillman, D M

“…In the vast majority of psoriatic patients, psoriatic lesions are localised on the body as well as on the scalp. Therefore, safety data on the combined use of…”
Get more information

610 ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AND PROGNOSIS IN ACUTE ISCHEMIC STROKE by Smedbakken, L.M., Jensen, J.K., Hallén, J., Atar, D., Januzzi, J.L., Halvorsen, B., Aukrust, P., Ueland, T.

Get full text

Development of a food frequency questionnaire to estimate calcium intake of Asian, Hispanic, and white youth by Jensen, J.Keith, Gustafson, Deborah, Boushey, Carol J., Auld, Garry, Bock, Margaret Ann, Bruhn, Christine M., Gabel, Kathe, Misner, Scottie, Novotny, Rachel, Peck, Louise, Read, Marsha

“…To develop a food frequency questionnaire (FFQ) that estimates calcium intake of Asian, Hispanic, and white youth living in the western United States. A list…”
Get full text

614 FATTY ACID BINDING PROTEIN 4 AS A BIOMARKER OF CAROTID ATHEROSCLEROSIS AND OUTCOME IN PATIENTS WITH ACUTE ISCHEMIC STROKE by Holm, S., Ueland, T., Dahl, T.B., Michelsen, A.E., Skjelland, M., Russell, D., Krogh-Sørensen, K., Clausen, O.R., Atar, D., Januzzi, J.L., Aukrust, P., Jensen, J.K., Halvorsen, B.

Get full text

A ONE-YEAR, MULTICENTRE, RANDOMISED STUDY OF DEGARELIX, A GONADATROPHIN–RELEASING HORMONE (GNRH) RECEPTOR BLOCKER, IN PROSTATE CANCER PATIENTS by Van Poppel, H., De La Rosette, J., Persson, B.E., Jensen, J.K., Olesen, T.K.

Get full text